Certified by Founder Lodge
Mission Therapeutics
United Kingdom - Cambridge, Cambs
START UP
1 Disclosed Funding Rounds $32,101,650
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Mission Therapeutics is a private, drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat diseases of high unmet need.
Mission has built
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 15 ,2024 | Unknown | $32,101,650 | |
| October, 15 ,2025 | Unknown | $13,300,000.00 |
Pfizer
Sofinnova Partners
SR One Capital Management
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
